Author Archives: CJ

About CJ

A clinician! Physician and a great doctor practicing for more than 5 years.

everest climbing line

Everest Rescue Insurance Fraud: The Dark Side of Himalayan Tourism

Introduction

For decades, climbing Mount Everest has symbolized human endurance, ambition, and adventure. But beneath the icy peaks and heroic summits, a disturbing reality has emerged—one that threatens not only climbers’ safety but also the integrity of Nepal’s tourism industry.

Recent investigations have exposed a multi-million-dollar insurance fraud scheme centered around unnecessary—and sometimes deliberately staged—helicopter rescues in the Everest region.


What Is the Everest Rescue Insurance Fraud?

The Everest rescue insurance fraud refers to a coordinated system in which trekking guides, helicopter companies, hospitals, and agents allegedly collaborate to generate false or exaggerated medical emergencies. These fake emergencies trigger costly helicopter evacuations, which are then billed to international insurance companies.

Between 2022 and 2025:

  • Over 300 suspicious rescues were identified (www.ndtv.com)
  • Fraudulent claims reached nearly $20 million (www.ndtv.com)
  • Thousands of climbers may have been affected (People.com)

This is not a small scam—it is a systemic exploitation of high-altitude rescue systems.


How the Scam Works

The fraud relies on the unique environment of the Himalayas, where medical uncertainty and remoteness create opportunities for manipulation.

Typical Pattern:

  1. A trekker develops mild symptoms (headache, fatigue, nausea).
  2. A guide exaggerates the risk of acute mountain sickness.
  3. The trekker is pressured into evacuation “for safety.”
  4. A helicopter is called—often unnecessarily.
  5. The patient is admitted to a hospital in Kathmandu.
  6. Insurance companies are billed for:
    • Helicopter rescue
    • Hospital admission
    • Medical treatment

In many cases, investigators found:

  • Falsified medical reports
  • Inflated billing
  • Multiple claims from a single flight (Summiters Club)

More Sinister Allegations

Some reports suggest even darker practices.

  • Guides allegedly induced symptoms using substances like baking soda or excessive medication
  • Tourists were made to believe they were seriously ill
  • In extreme cases, this has been described as “manufactured emergencies” (People.com)

Authorities have charged dozens of individuals, including guides and medical personnel, in connection with these activities (The Times of India)


Why This Fraud Was Possible

1. Information Asymmetry

Most trekkers lack medical knowledge and rely heavily on guides for decisions. Fear of altitude sickness makes evacuation an easy choice.

2. High Financial Incentives

  • A single helicopter rescue can cost thousands of dollars
  • Insurance companies often cover these costs without immediate verification

3. Remote Geography

  • No real-time verification in high-altitude zones
  • Documentation is reviewed only after evacuation

4. Weak Regulation

Despite earlier reforms after a 2018 scandal, enforcement gaps allowed the fraud to continue and expand (Summiters Club)


Impact on Nepal’s Tourism Industry

The consequences extend far beyond financial fraud.

Loss of Trust

International insurers have raised concerns about covering rescues in Nepal, potentially:

  • Increasing premiums
  • Limiting coverage
  • Delaying approvals for genuine emergencies

Risk to Real Patients

If insurers lose confidence:

  • Legitimate rescue cases may face delays
  • Life-saving evacuations could become harder to access

Damage to Reputation

Nepal’s global image as a premier trekking destination has been affected, especially during major climbing seasons (The Times of India)


Government Crackdown and Reforms

Authorities, including Nepal Police’s Central Investigation Bureau, have:

  • Filed organized crime charges
  • Arrested suspects linked to rescue companies
  • Investigated hospitals and helicopter operators
  • Introduced stricter monitoring systems

New measures include:

  • Better documentation of rescues
  • Accountability of trekking agencies
  • Closer scrutiny of insurance claims

Ethical and Medical Perspective

From a medical standpoint, this scandal is deeply concerning.

  • It exploits genuine fear of altitude illness
  • It may expose patients to unnecessary evacuation risks
  • It undermines trust in medical professionals and rescue systems

For healthcare providers and trekkers alike, this raises a critical question:

When is a rescue truly necessary—and who decides?


Conclusion

The Everest rescue insurance fraud reveals a troubling paradox:
In a place where helicopters are meant to save lives, they were sometimes used to generate profit.

While the majority of rescues in the Himalayas remain legitimate and life-saving, this scandal highlights the urgent need for:

  • Stronger regulation
  • Ethical accountability
  • Better medical oversight

For Nepal, the challenge now is clear—restore trust in a system where every rescue should mean survival, not exploitation.

Macrocytic Anemia: A Clinical Overview (Based on Nelson Textbook of Pediatrics)

Macrocytic anemia is a hematological condition characterized by the presence of enlarged red blood cells (RBCs), typically reflected by an increased mean corpuscular volume (MCV >100 fL). In pediatric practice, as outlined in Nelson Textbook of Pediatrics, macrocytic anemia represents an important diagnostic category that often signals underlying nutritional deficiencies, bone marrow disorders, or systemic disease.


Classification of Macrocytic Anemia

Macrocytic anemia can broadly be divided into:

  1. Megaloblastic Macrocytic Anemia
    • Caused by impaired DNA synthesis
    • Characterized by megaloblasts in the bone marrow
  2. Non-Megaloblastic Macrocytic Anemia
    • Not associated with defective DNA synthesis
    • Often due to membrane abnormalities or increased reticulocyte count

Etiology

1. Megaloblastic Causes

  • Vitamin B12 deficiency
    • Dietary deficiency (rare in children unless strict vegan diet)
    • Malabsorption (e.g., pernicious anemia, ileal disease)
  • Folate deficiency
    • Poor dietary intake
    • Increased requirement (e.g., infancy, hemolytic anemia)
    • Malabsorption syndromes

2. Non-Megaloblastic Causes

  • Liver disease
  • Hypothyroidism
  • Reticulocytosis (e.g., hemolysis, blood loss)
  • Bone marrow disorders (e.g., aplastic anemia, myelodysplasia)
  • Drug-induced (e.g., anticonvulsants, chemotherapy)

Pathophysiology

In megaloblastic anemia, impaired DNA synthesis leads to delayed nuclear maturation while cytoplasmic development proceeds normally. This nuclear-cytoplasmic asynchrony results in large, immature erythroid precursors (megaloblasts) and macrocytic RBCs in circulation.

Vitamin B12 and folate are essential cofactors in DNA synthesis. Deficiency of either disrupts thymidine production, impairing cell division.


Clinical Features

Clinical presentation varies depending on severity and cause:

  • General symptoms
    • Pallor
    • Fatigue
    • weakness
  • Gastrointestinal
    • Glossitis (smooth, red tongue)
    • Poor appetite
  • Neurological (especially in B12 deficiency)
    • Paresthesia
    • Ataxia
    • Developmental delay (in infants)

Laboratory Findings

  • Elevated MCV (>100 fL)
  • Hypersegmented neutrophils (hallmark of megaloblastic anemia)
  • Low hemoglobin
  • Peripheral smear: macro-ovalocytes
  • Serum levels:
    • ↓ Vitamin B12
    • ↓ Folate
  • Elevated homocysteine (both deficiencies)
  • Elevated methylmalonic acid (specific for B12 deficiency)

Diagnosis

Diagnosis involves:

  1. Complete blood count (CBC)
  2. Peripheral blood smear
  3. Serum vitamin B12 and folate levels
  4. Bone marrow examination (if unclear or severe cases)

Management

Vitamin B12 Deficiency

  • Parenteral B12 (cyanocobalamin or hydroxocobalamin)
  • Lifelong therapy in irreversible causes

Folate Deficiency

  • Oral folic acid supplementation
  • Treat underlying cause

⚠️ Important: Always rule out B12 deficiency before treating folate deficiency alone, as folate can worsen neurological symptoms of B12 deficiency.


Complications

  • Neurological deficits (irreversible if untreated)
  • Growth retardation in children
  • Increased risk of infections due to pancytopenia

Prevention

  • Adequate dietary intake (green leafy vegetables, animal products)
  • Supplementation in high-risk groups
  • Early detection in infants and children

Conclusion

Macrocytic anemia in children requires a systematic approach to identify underlying causes. As emphasized in Nelson Textbook of Pediatrics, distinguishing between megaloblastic and non-megaloblastic anemia is critical for appropriate management. Early diagnosis and treatment can prevent serious complications, particularly irreversible neurological damage in vitamin B12 deficiency.


Diamond-Blackfan anemia

Diamond-Blackfan anemia (DBA) is a rare congenital blood disorder characterized by the failure of the bone marrow to produce red blood cells. It usually presents in infancy and is classified as a congenital pure red cell aplasia. DBA is notable for its genetic basis, variable physical malformations, and lifelong management challenges.

Key facts

  • Onset: Typically within the first year of life
  • Genetic cause: Mutations in ribosomal protein genes
  • Inheritance pattern: Autosomal dominant (most cases de novo)
  • Prevalence: About 5–7 per million live births
  • Treatment options: Corticosteroids, chronic transfusions, or stem cell transplantation

Pathophysiology

Diamond-Blackfan anemia arises from mutations that impair ribosome biogenesis, leading to defective erythroid progenitor development. The bone marrow becomes selectively deficient in red cell precursors, while white cells and platelets remain normal. Most cases involve mutations in genes encoding ribosomal proteins such as RPS19RPL5, or RPL11, disrupting protein synthesis and cellular growth.

Clinical features

Infants with DBA commonly present with pallor and anemia. Physical anomalies are present in about half of cases, including craniofacial abnormalities, thumb or limb malformations, and heart or kidney defects. Growth retardation and an increased lifetime risk of malignancies such as leukemia and osteogenic sarcoma are recognized complications.

Diagnosis

Diagnosis combines hematologic findings—macrocytic anemia, reticulocytopenia, and normal marrow cellularity except for absent red cell precursors—with genetic testing for ribosomal protein gene mutations. Elevated erythrocyte adenosine deaminase (eADA) activity is a common biomarker.

Management and prognosis

Initial treatment often involves corticosteroids to stimulate red cell production. Patients unresponsive to steroids may require regular transfusions with iron chelation therapy to prevent overload, or hematopoietic stem cell transplantation as a potential cure. Advances in genetic understanding have improved prognosis, but lifelong monitoring remains essential due to treatment complications and cancer risk.

Does Sex Increase Breast or Butt Size in Women?

(A Scientific, Myth-Busting Blog with Visual Explanation)


Introduction

This is one of the most common myths people believe:
👉 “Regular sex makes breasts and butt bigger.”

It sounds believable—because sex involves hormones, body changes, and physical stimulation. But what does actual medical science say?

Let’s break it down with evidence.


What Happens to the Body During Sex?

7

During sexual arousal and orgasm, several temporary physiological changes occur:

Increased blood flow

  • Blood vessels dilate (vasocongestion)
  • Breasts may appear fuller and slightly enlarged

Hormonal release

  • Oxytocin, dopamine, estrogen, progesterone rise
  • Nipples become erect and more sensitive

Temporary swelling effect

  • Breasts can appear 15–25% larger during arousal

👉 But here’s the key:
These changes are temporary and reverse after sex.


Does Sex Cause Permanent Breast Growth?

Short answer: No.

Scientific evidence clearly shows:

  • Breast size is mainly determined by:
    • Genetics
    • Body fat
    • Hormonal changes (puberty, pregnancy, medications)
  • Sex does NOT cause permanent breast enlargement

Even repeated sexual activity does not stimulate long-term tissue growth.


What Actually Increases Breast Size?

6

Real, evidence-based factors:

1. Genetics

  • The biggest determinant of size and shape

2. Body weight / fat

  • Breasts are largely fatty tissue
  • Weight gain → size increase

3. Hormones

  • Estrogen & progesterone drive growth
  • Seen during:
    • Puberty
    • Pregnancy
    • Hormonal therapy

4. Pregnancy & lactation

  • Causes true enlargement due to glandular growth

What About Buttocks Size?

6

Does sex increase butt size?

No — not directly.

Buttocks size depends on:

  • Fat distribution (influenced by estrogen)
  • Muscle mass (gluteal muscles)
  • Genetics
  • Exercise (e.g., squats, hip thrusts)

Sex does not stimulate fat deposition or muscle growth in the buttocks.


Why Do People Believe This Myth?

Several reasons:

1. Temporary swelling during sex

  • Breasts look bigger → mistaken as permanent

2. Hormonal timing confusion

  • Women may notice changes during:
    • Ovulation
    • Menstrual cycle
  • These are hormone-driven, not sex-driven

3. Cultural myths

  • Similar to:
    • “Marriage increases breast size” (also false)

Final Scientific Verdict

What sex DOES do:

  • Temporary breast fullness
  • Nipple erection
  • Increased sensitivity
  • Short-term hormonal fluctuations

What sex DOES NOT do:

  • Permanently increase breast size
  • Increase butt size
  • Change body fat distribution

Clinical Bottom Line (For Medical Perspective)

  • Breast size = fat + glandular tissue + hormones
  • Butt size = fat distribution + muscle mass
  • Sex = transient physiological response only

Conclusion

Sex may make breasts look bigger for a short time, but it does not cause real growth.
Butt size is completely unrelated to sexual activity.

This is a classic biological myth—explained by temporary changes and misunderstood hormones.

The Complete Clinical Approach to Vomiting in Pediatrics

A structured, practical guide for clinicians


Introduction

Vomiting is one of the most common presenting complaints in pediatric practice—ranging from benign, self-limiting illnesses to life-threatening surgical and metabolic emergencies. It is not a diagnosis, but a symptom with a broad differential, involving gastrointestinal (GI), neurological, metabolic, infectious, and psychological causes.

The real challenge is not treating vomiting—but identifying which child is sick and why.


Understanding Vomiting

Vomiting is a protective reflex involving coordinated contraction of abdominal muscles and relaxation of the lower esophageal sphincter, leading to expulsion of gastric contents.

Types of Vomiting

  • Acute vomiting → hours to days (e.g., gastroenteritis)
  • Chronic vomiting → weeks (e.g., GERD, metabolic causes)
  • Cyclic vomiting → episodic with symptom-free intervals
  • Projectile vomiting → suggests obstruction (e.g., pyloric stenosis)
  • Bilious vomiting (green) → surgical emergency until proven otherwise

Step 1: Initial Stabilization (ABC First)

Before thinking of diagnosis:

  • Airway → risk of aspiration
  • Breathing → respiratory distress?
  • Circulation → shock, dehydration

Assess:

  • Vitals
  • Capillary refill
  • Level of consciousness
  • Hydration status

👉 This step is critical because vomiting can rapidly lead to dehydration and electrolyte imbalance.


Step 2: Identify RED FLAG Signs

These determine urgency and need for immediate intervention:

Major Red Flags

  • Bilious (green) vomiting
  • Bloody vomiting
  • Altered sensorium
  • Severe dehydration
  • Persistent projectile vomiting
  • Abdominal distension or peritonitis
  • Inconsolable crying (infants)
  • Neck stiffness + fever (meningitis)
  • Morning vomiting + headache (raised ICP)

These features suggest serious pathology such as:

  • Intestinal obstruction
  • Intussusception
  • Meningitis
  • Intracranial hypertension
  • Appendicitis

Step 3: Age-Based Differential Diagnosis

Age is one of the most powerful diagnostic clues.

1. Neonates (0–28 days)

Think danger first:

  • Intestinal obstruction (atresia, malrotation)
  • Hirschsprung disease
  • Sepsis
  • Inborn errors of metabolism

👉 Bilious vomiting = surgical emergency


2. Infants

  • Gastroesophageal reflux (common)
  • Pyloric stenosis → projectile vomiting
  • Intussusception
  • Food allergy
  • Infection

3. Children

  • Acute gastroenteritis (most common)
  • Appendicitis
  • UTI
  • Pneumonia (post-tussive vomiting)
  • Migraine

4. Adolescents

  • Pregnancy
  • Eating disorders
  • Drug/toxin ingestion
  • Diabetic ketoacidosis (DKA)
  • Intracranial causes

Step 4: Focused History

A good history often gives the diagnosis.

Key Questions

  1. Onset
    • Sudden → infection, obstruction
    • Chronic → GERD, metabolic
  2. Character of Vomit
    • Bilious → obstruction
    • Projectile → pyloric stenosis
    • Blood → gastritis, ulcer
  3. Relation to Feeding
    • Immediately after feeds → reflux
    • Delayed → obstruction
  4. Associated Symptoms
    • Fever → infection
    • Diarrhea → gastroenteritis
    • Headache → intracranial cause
    • Abdominal pain → surgical cause
  5. Systemic Clues
    • Poor weight gain → chronic disease
    • Polyuria → DKA
    • Drug ingestion → toxins

Step 5: Physical Examination

General Examination

  • Hydration status:
    • Sunken eyes
    • Dry mucosa
    • Reduced urine output
  • Growth parameters (failure to thrive?)

Systemic Examination

Abdomen

  • Distension → obstruction
  • Tenderness → appendicitis
  • Mass → intussusception

CNS

  • Bulging fontanelle (infants)
  • Neck stiffness
  • Altered consciousness

Skin

  • Rash → infection/allergy
  • Petechiae → sepsis

Step 6: Investigations

👉 No “routine panel” exists — investigations should be targeted.

Basic Investigations

  • Serum electrolytes
  • Blood glucose
  • Blood gas (if severe)

When Indicated

  • Imaging
    • X-ray abdomen → obstruction
    • Ultrasound → intussusception
    • CT/MRI → CNS causes
  • Other tests
    • Urine analysis → UTI
    • LFT/RFT → systemic disease
    • Metabolic screening

Step 7: Management Approach

1. Treat the Cause (Definitive)

  • Surgery → obstruction
  • Antibiotics → infection
  • Insulin → DKA

2. Correct Dehydration (MOST IMPORTANT)

Mild–Moderate:

  • Oral Rehydration Therapy (ORT)

Severe:

  • IV fluids (bolus + maintenance)

3. Symptomatic Treatment

  • Ondansetron for persistent vomiting
  • NG decompression in obstruction
  • Electrolyte correction

4. Nutritional Support

  • Early feeding when tolerated
  • Continue breastfeeding

Step 8: Clinical Patterns to Recognize (Exam Gold)

PatternLikely Diagnosis
Projectile, non-biliousPyloric stenosis
Bilious vomitingIntestinal obstruction
Vomiting + diarrheaGastroenteritis
Vomiting + headache (morning)Raised ICP
Vomiting + abdominal pain → laterAppendicitis
Episodic vomiting, symptom-free intervalsCyclic vomiting

Common Pitfalls

  • Ignoring bilious vomiting
  • Missing appendicitis early
  • Assuming all vomiting = gastroenteritis
  • Not checking hydration status
  • Over-ordering unnecessary tests

Clinical Algorithm (Simple Mental Model)

  1. Is the child sick? (ABC + red flags)
  2. What is the age?
  3. What is the type of vomiting?
  4. What are associated symptoms?
  5. Targeted investigations
  6. Treat dehydration + cause

Key Takeaways

  • Most pediatric vomiting is benign and self-limiting
  • But always rule out life-threatening causes first
  • Age + vomiting type + red flags = diagnosis
  • Hydration management saves lives

Conclusion

Vomiting in children is a diagnostic puzzle—but a structured approach simplifies it. The goal is not to memorize hundreds of causes, but to quickly identify danger, localize the system involved, and act appropriately.

DEXTROSE INFUSION RATE (GIR) IN NEONATAL HYPOGLYCEMIA

1. Definition

GIR (Glucose Infusion Rate) = amount of glucose delivered per kg body weight per minute.

👉 Unit: mg/kg/min


2. Formula

GIR=Dextrose (%) ×Infusion rate (mL/kg/day)144GIR = \frac{\text{Dextrose (\%) } \times \text{Infusion rate (mL/kg/day)}}{144}GIR=144Dextrose (%) ×Infusion rate (mL/kg/day)​

👉 Alternate (commonly used in ICU):GIR=Dextrose (g/mL)×mL/kg/min×10001GIR = \frac{\text{Dextrose (g/mL)} \times \text{mL/kg/min} \times 1000}{1}GIR=1Dextrose (g/mL)×mL/kg/min×1000​


3. Normal Glucose Requirement (Term Neonate)

AgeGIR (mg/kg/min)
First 24 hrs4–6
After 24 hrs5–8

4. Treatment of Hypoglycemia

Symptomatic OR RBS <40 mg/dL

Step 1: Bolus

  • 10% Dextrose
  • Dose: 2 mL/kg IV bolus

Step 2: Continuous Infusion

SeverityStarting GIR
Mild4–6 mg/kg/min
Moderate6–8 mg/kg/min
Severe/refractory8–12 mg/kg/min

5. Escalation Strategy

  • Increase GIR by 2 mg/kg/min every 30–60 min
  • Max GIR: 12–15 mg/kg/min (sometimes up to 20 in refractory cases)

👉 If still hypoglycemic:

  • Consider:
    • Sepsis
    • Hyperinsulinism
    • Endocrine causes

6. Practical Conversion Table

GIR (mg/kg/min)D10 Rate (mL/kg/day)
460
575
690
8120
10150

👉 Quick memory:
D10 @ 80–100 mL/kg/day ≈ GIR 5–7


7. When High GIR Needed (>8–10)

Think:

  • Hyperinsulinism
  • Sepsis
  • Inborn errors of metabolism
  • Hypopituitarism
  • Adrenal insufficiency

8. Choice of Dextrose Concentration

FluidUse
D10First-line
D12.5Peripheral max
D15–D25Central line only

9. Monitoring

  • RBS every 30–60 min initially
  • Then every 4–6 hrs
  • Watch for:
    • Rebound hypoglycemia
    • Fluid overload

10. Weaning

  • Reduce GIR gradually once stable (>50–60 mg/dL)
  • Start/advance enteral feeds

Exam Pearls

  • First step = D10 bolus (2 mL/kg)
  • Target glucose >45 mg/dL
  • GIR >8 = suspect pathology
  • Max peripheral dextrose = 12.5%
  • Persistent hypoglycemia → think hyperinsulinism